{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:37:56Z","timestamp":1792521476044,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004705","name":"King Mongkut's University of Technology Thonburi","doi-asserted-by":"publisher","award":["Petchra Pra Jom Klao a Ph.D. scholarship from King Mongkut\u2019s University of Technology Thonburi"],"award-info":[{"award-number":["Petchra Pra Jom Klao a Ph.D. scholarship from King Mongkut\u2019s University of Technology Thonburi"]}],"id":[{"id":"10.13039\/501100004705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004705","name":"King Mongkut's University of Technology Thonburi","doi-asserted-by":"publisher","award":["Thailand."],"award-info":[{"award-number":["Thailand."]}],"id":[{"id":"10.13039\/501100004705","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s12033-025-01403-x","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T13:17:36Z","timestamp":1740748656000},"page":"723-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Influenza Neuraminidase Virus-Like Particle-Based Nanocarriers as a New Platform for the Delivery of Small-Peptide Antigens"],"prefix":"10.1007","volume":"68","author":[{"given":"Najmeh","family":"Khanefard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irisa","family":"Trianti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saengchai","family":"Akeprathumchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phenjun","family":"Mekvichitsaeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowaluck Maprang","family":"Roshorm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3301-6952","authenticated-orcid":false,"given":"Kanokwan","family":"Poomputsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"1403_CR1","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nri3689","volume":"14","author":"B Heesters","year":"2014","unstructured":"Heesters, B., Myers, R., & Carroll, M. (2014). Follicular dendritic cells: Dynamic antigen libraries. Nature Reviews Immunology, 14, 495\u2013504. https:\/\/doi.org\/10.1038\/nri3689","journal-title":"Nature Reviews Immunology"},{"issue":"Pt B","key":"1403_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.nbt.2017.07.010","volume":"39","author":"J Fuenmayor","year":"2017","unstructured":"Fuenmayor, J., G\u00f2dia, F., & Cervera, L. (2017). Production of virus-like particles for vaccines. New Biotechnology, 39(Pt B), 174\u2013180. https:\/\/doi.org\/10.1016\/j.nbt.2017.07.010","journal-title":"New Biotechnology"},{"key":"1403_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00226","author":"AC Gomes","year":"2017","unstructured":"Gomes, A. C., Flace, A., Saudan, P., Zabel, F., Cabral-Miranda, G., Turabi, A. E., Manolova, V., & Bachmann, M. F. (2017). Adjusted particle size eliminates the need of linkage of antigen and adjuvants for appropriated T cell responses in virus-like particle-based vaccines. Frontiers in Immunology. https:\/\/doi.org\/10.3389\/fimmu.2017.00226","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"1403_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/vaccines6030037","volume":"6","author":"M Mohsen","year":"2018","unstructured":"Mohsen, M., Gomes, A., Vogel, M., & Bachmann, M. (2018). Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system. Vaccines, 6(3), 37. https:\/\/doi.org\/10.3390\/vaccines6030037","journal-title":"Vaccines"},{"issue":"11","key":"1403_CR5","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri286","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann, M. F., & Jennings, G. T. (2010). Vaccine delivery: A matter of size, geometry, kinetics and molecular patterns. Nature Reviews Immunology, 10(11), 787\u2013796. https:\/\/doi.org\/10.1038\/nri286","journal-title":"Nature Reviews Immunology"},{"key":"1403_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.smim.2017.08.014","volume":"34","author":"MO Mohsen","year":"2017","unstructured":"Mohsen, M. O., Zha, L., Cabral-Miranda, G., & Bachmann, M. F. (2017). Major findings and recent advances in virus\u2013like particle (VLP)-based vaccines. Seminars in Immunology, 34, 123\u2013132. https:\/\/doi.org\/10.1016\/j.smim.2017.08.014","journal-title":"Seminars in Immunology"},{"issue":"5","key":"1403_CR7","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.nano.2010.04.005","volume":"6","author":"NF Steinmetz","year":"2010","unstructured":"Steinmetz, N. F. (2010). Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. Nanomedicine: Nanotechnology, Biology and Medicine, 6(5), 634\u2013641. https:\/\/doi.org\/10.1016\/j.nano.2010.04.005","journal-title":"Nanomedicine: Nanotechnology, Biology and Medicine"},{"issue":"29","key":"1403_CR8","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1016\/j.vaccine.2015.04.073","volume":"33","author":"LM Tsybalova","year":"2015","unstructured":"Tsybalova, L. M., Stepanova, L. A., Kuprianov, V. V., Blokhina, E., Potapchuk, M. V., Korotkov, A. N., Gorshkov, A. N., Kasyanenko, M. A., Ravin, N. V., & Kiselev, O. I. (2015). Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e. Vaccine, 33(29), 3398\u20133406. https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.073","journal-title":"Vaccine"},{"key":"1403_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.06.024","author":"YH Chung","year":"2020","unstructured":"Chung, Y. H., Cai, H., & Steinmetz, N. F. (2020). Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications. Advanced Drug Delivery Reviews. https:\/\/doi.org\/10.1016\/j.addr.2020.06.024","journal-title":"Advanced Drug Delivery Reviews"},{"key":"1403_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-022-00519-8","author":"N Khanefard","year":"2022","unstructured":"Khanefard, N., Sapavee, S., Akeprathumchai, S., Mekvichitsaeng, P., & Poomputsa, K. (2022). Production of neuraminidase virus like particles by stably transformed insect cells: A simple process for NA-based influenza vaccine development. Molecular Biotechnology. https:\/\/doi.org\/10.1007\/s12033-022-00519-8","journal-title":"Molecular Biotechnology"},{"key":"1403_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00039","author":"JL McAuley","year":"2019","unstructured":"McAuley, J. L., Gilbertson, B. P., Trifkovic, S., Brown, L. E., & McKimm-Breschkin, J. L. (2019). Influenza virus neuraminidase structure and functions. Frontiers in Microbiology. https:\/\/doi.org\/10.3389\/fmicb.2019.00039","journal-title":"Frontiers in Microbiology"},{"issue":"8","key":"1403_CR12","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1128\/jvi.66.8.4647-4653.1992","volume":"66","author":"MR Castrucci","year":"1992","unstructured":"Castrucci, M. R., Bilsel, P., & Kawaoka, Y. (1992). Attenuation of influenza A virus by insertion of a foreign epitope into the neuraminidase. Journal of Virology, 66(8), 4647\u20134653. https:\/\/doi.org\/10.1128\/jvi.66.8.4647-4653.1992","journal-title":"Journal of Virology"},{"issue":"9","key":"1403_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7326\/0003-4819-139-9-200311040-00011","volume":"139","author":"S Oparil","year":"2003","unstructured":"Oparil, S., Zaman, M. A., & Calhoun, D. A. (2003). Pathogenesis of hypertension. Annals of Internal Medicine, 139(9), 761. https:\/\/doi.org\/10.7326\/0003-4819-139-9-200311040-00011","journal-title":"Annals of Internal Medicine"},{"issue":"9615","key":"1403_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S0140-6736(08)60381-5","volume":"371","author":"AC Tissot","year":"2008","unstructured":"Tissot, A. C., Maurer, P., Nussberger, J., Sabat, R., Pfister, T., Ignatenko, S., Volk, H.-D., Stocker, H., M\u00fcller, P., Jennings, G. T., Wagner, F., & Bachmann, M. F. (2008). Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure: A double-blind, randomised, placebo-controlled phase IIa study. Lancet (London, England), 371(9615), 821\u2013827. https:\/\/doi.org\/10.1016\/S0140-6736(08)60381-5","journal-title":"Lancet (London, England)"},{"issue":"3","key":"1403_CR15","doi-asserted-by":"publisher","first-page":"e60493","DOI":"10.1371\/journal.pone.0060493","volume":"8","author":"F Nakagami","year":"2013","unstructured":"Nakagami, F., Koriyama, H., Nakagami, H., Osako, M. K., Shimamura, M., Kyutoku, M., Miyake, T., Katsuya, T., Rakugi, H., & Morishita, R. (2013). Decrease in blood pressure and regression of cardiovascular complications by angiotensin II vaccine in mice. PLoS ONE, 8(3), e60493\u2013e60493. https:\/\/doi.org\/10.1371\/journal.pone.0060493","journal-title":"PLoS ONE"},{"issue":"1","key":"1403_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1161\/hypertensionaha.114.04534","volume":"66","author":"H Koriyama","year":"2015","unstructured":"Koriyama, H., Nakagami, H., Nakagami, F., Osako, M. K., Kyutoku, M., Shimamura, M., Kurinami, H., Katsuya, T., Rakugi, H., & Morishita, R. (2015). Long-term reduction of high blood pressure by angiotensin II DNA vaccine in spontaneously hypertensive rats. Hypertension, 66(1), 167\u2013174. https:\/\/doi.org\/10.1161\/hypertensionaha.114.04534","journal-title":"Hypertension"},{"key":"1403_CR17","doi-asserted-by":"publisher","first-page":"43920","DOI":"10.1038\/srep43920","volume":"7","author":"R Watanabe","year":"2017","unstructured":"Watanabe, R., Suzuki, J.-I., Wakayama, K., Maejima, Y., Shimamura, M., Koriyama, H., Nakagami, H., Kumagai, H., Ikeda, Y., Akazawa, H., Morishita, R., Komuro, I., & Isobe, M. (2017). A peptide vaccine targeting angiotensin II attenuates the cardiac dysfunction induced by myocardial infarction. Scientific Reports, 7, 43920. https:\/\/doi.org\/10.1038\/srep43920","journal-title":"Scientific Reports"},{"issue":"1","key":"1403_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41440-021-00755-6","volume":"45","author":"H Nakagami","year":"2022","unstructured":"Nakagami, H., Ishihama, T., Daikyoji, Y., Sasakura, C., Yamada, E., & Morishita, R. (2022). Brief report on a phase I\/IIa study to assess the safety, tolerability, and immune response of AGMG0201 in patients with essential hypertension. Hypertension Research, 45(1), 61\u201365. https:\/\/doi.org\/10.1038\/s41440-021-00755-6","journal-title":"Hypertension Research"},{"issue":"2","key":"1403_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1099\/vir.0.80368-0","volume":"86","author":"P Puthavathana","year":"2005","unstructured":"Puthavathana, P., Auewarakul, P., Charoenying, P. C., Sangsiriwut, K., Pooruk, P., Boonnak, K., Khanyok, R., Thawachsupa, P., Kijphati, R., & Sawanpanyalert, P. (2005). Molecular characterization of the complete genome of human influenza H5N1 virus isolates from Thailand. Journal of General Virology, 86(2), 423\u2013433. https:\/\/doi.org\/10.1099\/vir.0.80368-0","journal-title":"Journal of General Virology"},{"key":"1403_CR20","unstructured":"User Manual InsectSelect\u2122System for the Stable Expression of Heterologous Proteins in Lepidopteran Insect Cell Lines using pIZ\/V5-His. (2010). https:\/\/assets.fishersci.com\/TFS-Assets\/LSG\/manuals\/insectselpiz_man.pdf"},{"key":"1403_CR21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/B978-0-12-418687-3.00013-6","volume":"529","author":"CM Koh","year":"2013","unstructured":"Koh, C. M. (2013). Isolation of genomic DNA from mammalian cells. Methods in enzymology, 529, 161\u2013169. https:\/\/doi.org\/10.1016\/B978-0-12-418687-3.00013-6","journal-title":"Methods in enzymology"},{"issue":"1","key":"1403_CR22","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0042-6822(92)90297-3","volume":"187","author":"DA Theilmann","year":"1992","unstructured":"Theilmann, D. A., & Stewart, S. (1992). Molecular analysis of the trans-activating IE-2 gene of Orgyia pseudotsugata multicapsid nuclear polyhedrosis virus. Virology, 187(1), 84\u201396. https:\/\/doi.org\/10.1016\/0042-6822(92)90297-3","journal-title":"Virology"},{"issue":"2","key":"1403_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0378-1119(96)00756-1","volume":"188","author":"TA Pfeifer","year":"1997","unstructured":"Pfeifer, T. A., Hegedus, D. D., Grigliatti, T. A., & Theilmann, D. A. (1997). Baculovirus immediate-early promoter-mediated expression of the Zeocin\u2122 resistance gene for use as a dominant selectable marker in Dipteran and Lepidopteran insect cell lines. Gene, 188(2), 183\u2013190. https:\/\/doi.org\/10.1016\/s0378-1119(96)00756-1","journal-title":"Gene"},{"issue":"3","key":"1403_CR24","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1006\/prep.1998.1021","volume":"15","author":"DD Hegedus","year":"1999","unstructured":"Hegedus, D. D., Pfeifer, T. A., Theilmann, D. A., Kennard, M. L., Gabathuler, R., Jefferies, W. A., & Grigliatti, T. A. (1999). Differences in the expression and localization of human melanotransferrin in lepidopteran and dipteran insect cell lines. Protein Expression and Purification, 15(3), 296\u2013307. https:\/\/doi.org\/10.1006\/prep.1998.1021","journal-title":"Protein Expression and Purification"},{"key":"1403_CR25","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.1128\/jvi.69.8.5011-5017.1995","volume":"69","author":"T Saito","year":"1995","unstructured":"Saito, T., Taylor, G., & Webster, R. G. (1995). Steps in maturation of influenza A virus neuraminidase. Journal of Virology, 69, 5011\u20135017.","journal-title":"Journal of Virology"},{"issue":"1","key":"1403_CR26","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1074\/jbc.M112.424150","volume":"288","author":"DV da Silva","year":"2013","unstructured":"da Silva, D. V., Nordholm, J., Madjo, U., Pfeiffer, A., & Daniels, R. (2013). Assembly of subtype 1 influenza neuraminidase is driven by both the transmembrane and head domains. The Journal of biological chemistry, 288(1), 644\u2013653. https:\/\/doi.org\/10.1074\/jbc.M112.424150","journal-title":"The Journal of biological chemistry"},{"key":"1403_CR27","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.jip.2011.05.004","volume":"107","author":"T Vicente","year":"2011","unstructured":"Vicente, T., Rold\u00e3o, A., Peixoto, C., Carrondo, M. J. T., & Alves, P. M. (2011). Large-scale production and purification of VLP-based vaccines. Journal of Invertebrate Pathology, 107, S42\u2013S48. https:\/\/doi.org\/10.1016\/j.jip.2011.05.004","journal-title":"Journal of Invertebrate Pathology"},{"key":"1403_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-1417-3_9","author":"B Donaldson","year":"2014","unstructured":"Donaldson, B., Al-Barwani, F., Young, V., Scullion, S., Ward, V., & Young, S. (2014). Virus-like particles, a versatile subunit vaccine platform. Subunit Vaccine Delivery. https:\/\/doi.org\/10.1007\/978-1-4939-1417-3_9","journal-title":"Subunit Vaccine Delivery"},{"issue":"9","key":"1403_CR29","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1128\/jvi.61.9.2910-2916.1987","volume":"61","author":"RG Webster","year":"1987","unstructured":"Webster, R. G., Air, G. M., Metzger, D. W., Colman, P. M., Varghese, J. N., Baker, A. T., & Laver, W. G. (1987). Antigenic structure and variation in an influenza virus N9 neuraminidase. Journal of Virology, 61(9), 2910\u20132916. https:\/\/doi.org\/10.1128\/jvi.61.9.2910-2916.1987","journal-title":"Journal of Virology"},{"issue":"6","key":"1403_CR30","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.tim.2019.03.001","volume":"27","author":"F Wen","year":"2019","unstructured":"Wen, F., & Wan, X. F. (2019). Influenza neuraminidase: Underrated role in receptor binding. Trends in microbiology, 27(6), 477\u2013479. https:\/\/doi.org\/10.1016\/j.tim.2019.03.001","journal-title":"Trends in microbiology"},{"issue":"4","key":"1403_CR31","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1111\/irv.12001","volume":"7","author":"M Getie-Kebtie","year":"2012","unstructured":"Getie-Kebtie, M., Sultana, I., Eichelberger, M., & Alterman, M. (2012). Label-free mass spectrometry-based quantification of hemagglutinin and neuraminidase in influenza virus preparations and vaccines. Influenza and Other Respiratory Viruses, 7(4), 521\u2013530. https:\/\/doi.org\/10.1111\/irv.12001","journal-title":"Influenza and Other Respiratory Viruses"},{"issue":"19","key":"1403_CR32","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1016\/j.vaccine.2014.01.078","volume":"32","author":"I Sultana","year":"2014","unstructured":"Sultana, I., Yang, K., Getie-Kebtie, M., Couzens, L., Markoff, L., Alterman, M., & Eichelberger, M. C. (2014). Stability of neuraminidase in inactivated influenza vaccines. Vaccine, 32(19), 2225\u20132230. https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.078","journal-title":"Vaccine"},{"key":"1403_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jviromet.2017.02.015","volume":"244","author":"H Wan","year":"2017","unstructured":"Wan, H., Sultana, I., Couzens, L., Mindaye, S. T., & Eichelberger, M. C. (2017). Assessment of influenza A neuraminidase (subtype N1) potency by ELISA. Journal of Virological Methods, 244, 23\u201328. https:\/\/doi.org\/10.1016\/j.jviromet.2017.02.015","journal-title":"Journal of Virological Methods"},{"key":"1403_CR34","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00248-17","author":"D Changsom","year":"2017","unstructured":"Changsom, D., Jiang, L., Lerdsamran, H., Iamsirithaworn, S., Kitphati, R., Pooruk, P., Auewarakul, P., & Puthavathana, P. (2017). Kinetics, longevity, and cross-reactivity of antineuraminidase antibody after natural infection with influenza A viruses. Clinical and Vaccine Immunology. https:\/\/doi.org\/10.1128\/cvi.00248-17","journal-title":"Clinical and Vaccine Immunology"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-025-01403-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-025-01403-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-025-01403-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T04:55:04Z","timestamp":1772859304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-025-01403-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1403"],"URL":"https:\/\/doi.org\/10.1007\/s12033-025-01403-x","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"29 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Animal experiments were conducted under animal protocols approved by the Ethic Committee for Animal Experimentation of the Universitas Brawijaya, Indonesia (No.443-KEP-UB). No human subject was used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}